AbbVie’s ABBV mid-stage studies of emraclidine for schizophrenia failed to meet their primary endpoint. Shares of the company ...

The benchmarks just keep falling: A week after tying Morgan Wallen’s “Last Night” for the longest-running Billboard Hot 100 ...

An Extraordinary Gift This is my last regularly scheduled column for Morningstar. I am retiring from the company, for the ...

Taramasalata lovers have been struggling to get hold of the Greek mezze dip as UK supermarkets grapple with a shortage. Read ...

Teary-eyed delegates. Two feet lodged on a sticky floor. Purple-pink haze on stage. Singer in a black and white polka-dot puffy dress. A red Nord keyboard. I am amongst a crowd of fans, creatives, and ...

Its third quarter results are in the books and Beacon Securities analyst Doug Cooper still thinks there is money to be made ...

Achieved $49.3 million in OGSIVEO® (nirogacestat) net product revenue in the third quarter - - Long-term follow-up data from the Phase 3 DeFi trial of nirogacestat in adults with desmoid tumors highli ...

New preclinical data demonstrates that CMV antigens identified with Evaxion's AI-Immunology platform trigger targeted immune responses Results also showcase the successful design of a proprietary pref ...

The upcoming girl group with a unique & personalized pre-debut strategy will reveal its full lineup soon ahead of 2025 music.

MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology ...

OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2024, and provided operating and partner program updates.

Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET. Company Participants. Chia-Lin Simmons - Chief Executive Officer Mark Archer - Chief F ...